Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 58
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

AlphaFold prediction of structural ensembles of disordered proteins

AlphaFold prediction of structural ensembles of disorde...

 40

Hepatic vagal afferents convey clock-dependent signals to regulate circadian food intake

Hepatic vagal afferents convey clock-dependent signals ...

 43

SUMOylation of Warts kinase promotes neural stem cell reactivation

SUMOylation of Warts kinase promotes neural stem cell r...

 63